Form 4: VirnetX CEO Kendall Larsen Granted 80,000 Stock Options

VirnetX Holding Corp's President and CEO, Kendall Larsen, was granted 80,000 stock options with an exercise price of $20.22, vesting over four years.

Summary

• Kendall Larsen, President & CEO, Director, and 10% Owner of VirnetX Holding Corp (VHC), was granted a total of 80,000 stock options.
• The options have an exercise price of $20.22 per share.
• The grant date for these options was November 24, 2025, and they expire on November 24, 2035.
• One-quarter (1/4) of the total shares subject to the option will vest on the one-year anniversary of the grant date, with an additional 1/4 vesting on each subsequent annual anniversary, provided continuous service.
• In the event of a Change in Control, all unvested shares underlying the options will vest immediately prior to the consummation of the transaction.
• Of the 80,000 options, 50,000 are directly owned by Kendall Larsen, and 30,000 are indirectly owned by his spouse.

Sentiment

Score: 7

Explanation: The grant of stock options to the CEO is generally a positive signal, indicating management's long-term commitment and alignment with shareholder interests. It's a standard compensation practice, but the size and terms can influence sentiment. The fixed exercise price means the value is tied to future stock performance.

Positives

• The grant of 80,000 stock options to the CEO aligns management's interests with long-term shareholder value through performance-based incentives.
• The vesting schedule over four years encourages long-term commitment and retention of key leadership.
• The acceleration of vesting upon a Change in Control provides an incentive for management to consider strategic transactions that could benefit shareholders.

Negatives

• The exercise price of $20.22 is a fixed price, and the value of these options is contingent on the stock price exceeding this level in the future.
• Potential future dilution for existing shareholders if these options are exercised, although this is a standard aspect of equity compensation.

Risks

• The value of the stock options is entirely dependent on the future market performance of VirnetX Holding Corp's common stock.
• If the company's stock price does not exceed the exercise price of $20.22, the options may expire worthless.
• The vesting is contingent on continuous service, meaning the options could be forfeited if the CEO's service terminates before full vesting.

Future Outlook

The grant of these stock options indicates a long-term incentive structure for the CEO, aligning his financial interests with the company's future performance over the next decade, contingent on continued service and potential stock price appreciation above the exercise price.

Industry Context

Executive stock option grants are a common form of compensation in the technology and intellectual property licensing sectors, like VirnetX, designed to incentivize leadership to drive long-term growth and shareholder value. The structure, including vesting and change-in-control provisions, is typical for such arrangements.

Comparison to Industry Standards

• The grant of stock options as a significant component of executive compensation is a standard practice across many industries, particularly in growth-oriented technology companies.
• A four-year vesting schedule with annual increments is a common industry standard for executive equity awards, balancing retention with performance incentives.
• Provisions for accelerated vesting upon a change in control are also standard in executive compensation agreements, designed to protect executive interests during M&A activities and ensure smooth transitions.

Stakeholder Impact

• Shareholders: Potential for long-term value creation if the CEO's incentives lead to increased stock price. Potential for minor dilution upon exercise of options.
• Employees: May signal stability in leadership and a commitment to long-term strategy.
• Management: Provides significant long-term incentive and compensation tied to company performance.

Next Steps

• The first tranche of 1/4 of the options will vest on November 24, 2026, assuming continuous service.
• Subsequent tranches will vest annually thereafter until fully vested on November 24, 2029 (assuming a four-year vesting period).

Key Dates

Recommendation

This Form 4 filing reports a standard executive compensation event (stock option grant) and does not contain information that would fundamentally alter the investment thesis for VirnetX Holding Corp. While it aligns management incentives, it doesn't provide new operational or financial performance data to warrant a change in recommendation. Investors should 'hold' and continue to monitor the company's core business performance and financial results.

Keywords

VirnetX Holding Corp, VHC, Kendall Larsen, Stock Options, Executive Compensation, Insider Transaction, Form 4, Equity Incentive Plan, Vesting Schedule, Change in Control